Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-23T18:44:53.110Z Has data issue: false hasContentIssue false

Cognitive Screening Scale for Schizophrenia (CSSS): The Development and the Structure of the Scale

Published online by Cambridge University Press:  23 March 2020

A. Szulc
Affiliation:
Medical University of Warsaw, Department of Psychiatry, Pruszkow, Poland
J. Gierus
Affiliation:
Medical University of Warsaw, Department of Psychiatry, Pruszkow, Poland
T. Koweszko
Affiliation:
Medical University of Warsaw, Department of Psychiatry, Pruszkow, Poland
A. Mosiolek
Affiliation:
Medical University of Warsaw, Department of Psychiatry, Pruszkow, Poland

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objectives

The study presents the construction of CSSS: a short screening scale intended for diagnosis of cognitive deficits among people with schizophrenia. The final version of the scale consist of 6 subscales which measure basic cognitive functions.

Methods

A total of 160 persons (124 with schizophrenia and 36 healthy controls) were tested using the initial version of the CSSS scale consisting of 11 subscales. Correlation analysis between the subscale results was carried out, as well as confirmatory factor analysis, internal consistency analysis of the scale, IRT (item response theory) analysis of the item's difficulty, and analysis of the scale's accuracy as a classifier.

Results

One factor explains 37% of the variance of the subscales’ results. The scale has satisfactory internal consistency (0,83). Subjects with schizophrenia achieved significantly lower scores than healthy subjects. The area under the ROC curve (AUC) for discriminating between subjects with schizophrenia and healthy subjects was 0.83. Cut point of 16 raw points is 86% sensitive and has 70% specificity.

Conclusions

The form of the tool that has been achieved as a result of presented analyses suggests that this scale has a potential to fulfill the assumed goals, which will be tested during continuing validation studies.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
Oral communications: Genetics & molecular neurobiology; neuroimaging; psychosurgery & stimulation methods (ECT, TMS, VNS, DBS) and others
Copyright
Copyright © European Psychiatric Association 2017
Submit a response

Comments

No Comments have been published for this article.